UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 38

Sortiert nach

Higher latitude is significantly associated with an earlier age of disease onset in multiple sclerosis

Journal of neurology, neurosurgery and psychiatry, 2016-12, Vol.87 (12), p.1343-1349

2016

Volltextzugriff (PDF)

Predictors and dynamics of postpartum relapses in women with multiple sclerosis

Multiple sclerosis, 2014-05, Vol.20 (6), p.739-746

2014

Volltextzugriff (PDF)

Prognostic indicators in pediatric clinically isolated syndrome

Annals of neurology, 2017-05, Vol.81 (5), p.729-739

2017

Volltextzugriff (PDF)

The effect of oral immunomodulatory therapy on treatment uptake and persistence in multiple sclerosis

Multiple sclerosis, 2016-04, Vol.22 (4), p.520-532

2016

Volltextzugriff (PDF)

Country, sex, EDSS change and therapy choice independently predict treatment discontinuation in multiple sclerosis and clinically isolated syndrome

PloS one, 2012-06, Vol.7 (6), p.e38661-e38661

2012

Volltextzugriff (PDF)

HLA-DRB1 typing in Caucasians patients with neuromyelitis optica

Revista de neurologiá, 2011-08, Vol.53 (3), p.146-152

2011

Volltextzugriff (PDF)

Lipid-specific immunoglobulin M bands in cerebrospinal fluid are associated with a reduced risk of developing progressive multifocal leukoencephalopathy during treatment with natalizumab

Annals of neurology, 2015-03, Vol.77 (3), p.447-457

2015

Volltextzugriff (PDF)

Male Sex Is Independently Associated with Faster Disability Accumulation in Relapse-Onset MS but Not in Primary Progressive MS

PloS one, 2015-06, Vol.10 (6), p.e0122686-e0122686

2015

Volltextzugriff (PDF)

Important Role of Oxidative Stress Biomarkers in Huntington’s Disease

Journal of medicinal chemistry, 2011-08, Vol.54 (15), p.5602-5606

2011

Volltextzugriff (PDF)

Sex as a determinant of relapse incidence and progressive course of multiple sclerosis

Brain (London, England : 1878), 2013-12, Vol.136 (Pt 12), p.3609-3617

2013

Volltextzugriff (PDF)

Association of Initial Disease-Modifying Therapy With Later Conversion to Secondary Progressive Multiple Sclerosis

JAMA : the journal of the American Medical Association, 2019-01, Vol.321 (2), p.175

2019

Volltextzugriff (PDF)

Electrolytes Disturbances and Seizures

Epilepsia (Copenhagen), 2006-12, Vol.47 (12), p.1990-1998

2006

Volltextzugriff (PDF)

Seasonal variation of relapse rate in multiple sclerosis is latitude dependent

Annals of neurology, 2014-12, Vol.76 (6), p.880-890

2014

Volltextzugriff (PDF)

Examining the environmental risk factors of progressive-onset and relapsing-onset multiple sclerosis: recruitment challenges, potential bias, and statistical strategies

Journal of neurology, 2024-01, Vol.271 (1), p.472-485

2024

Volltextzugriff (PDF)

Risk of relapse phenotype recurrence in multiple sclerosis

Multiple sclerosis, 2014-10, Vol.20 (11), p.1511-1522

2014

Volltextzugriff (PDF)

Long-term disability trajectories in primary progressive MS patients: A latent class growth analysis

Multiple sclerosis, 2018-04, Vol.24 (5), p.642-652

2018

Volltextzugriff (PDF)

Comparative effectiveness of glatiramer acetate and interferon beta formulations in relapsing–remitting multiple sclerosis

Multiple sclerosis, 2015-08, Vol.21 (9), p.1159-1171

2015

Volltextzugriff (PDF)

Persistence on therapy and propensity matched outcome comparison of two subcutaneous interferon beta 1a dosages for multiple sclerosis

PloS one, 2013-05, Vol.8 (5), p.e63480

2013

Volltextzugriff (PDF)

Oxidative stress and inflammation biomarkers in the blood of patients with Huntington's disease

Neurological research (New York), 2012-09, Vol.34 (7), p.721-724

2012

Volltextzugriff (PDF)

NGF and nitrosative stress in patients with Huntington's disease

Journal of the neurological sciences, 2012-04, Vol.315 (1), p.133-136

2012

Volltextzugriff (PDF)

Multiple sclerosis in Latin America: A different disease course severity? A collaborative study from the MSBase Registry

Multiple sclerosis journal - experimental, translational and clinical, 2015-08, Vol.1, p.2055217315600193-2055217315600193

2015

Volltextzugriff (PDF)

1 – 25 von 38

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(38)
Mit Volltextzugriff
(33)

Publikationsform

Artikel
(38)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Revista De Neurologiá
(9)
Multiple Sclerosis
(5)
Annals Of Neurology
(4)
Brain
(3)
Plos One
(3)
Neurology
(2)
Annals Of Clinical And Translational Neurology
(1)
Epilepsia
(1)
Jama
(1)
Jama : The Journal Of The American Medical Association
(1)

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Higher latitude is significantly associated with an earlier age of disease onset in multiple sclerosis

Defining reliable disability outcomes in multiple sclerosis

Predictors of disability worsening in clinically isolated syndrome

Switch to natalizumab versus fingolimod in active relapsing-remitting multiple sclerosis

Predictors and dynamics of postpartum relapses in women with multiple sclerosis

Prognostic indicators in pediatric clinically isolated syndrome

The effect of oral immunomodulatory therapy on treatment uptake and persistence in multiple sclerosis

Country, sex, EDSS change and therapy choice independently predict treatment discontinuation in multiple sclerosis and clinically isolated syndrome

Comparison of switch to fingolimod or interferon beta/glatiramer acetate in active multiple sclerosis

HLA-DRB1 typing in Caucasians patients with neuromyelitis optica

Lipid-specific immunoglobulin M bands in cerebrospinal fluid are associated with a reduced risk of developing progressive multifocal leukoencephalopathy during treatment with natalizumab

Male Sex Is Independently Associated with Faster Disability Accumulation in Relapse-Onset MS but Not in Primary Progressive MS

Important Role of Oxidative Stress Biomarkers in Huntington’s Disease

Sex as a determinant of relapse incidence and progressive course of multiple sclerosis

Association of Initial Disease-Modifying Therapy With Later Conversion to Secondary Progressive Multiple Sclerosis

Electrolytes Disturbances and Seizures

Seasonal variation of relapse rate in multiple sclerosis is latitude dependent

Examining the environmental risk factors of progressive-onset and relapsing-onset multiple sclerosis: recruitment challenges, potential bias, and statistical strategies

Risk of relapse phenotype recurrence in multiple sclerosis

Long-term disability trajectories in primary progressive MS patients: A latent class growth analysis

Comparative effectiveness of glatiramer acetate and interferon beta formulations in relapsing–remitting multiple sclerosis

Persistence on therapy and propensity matched outcome comparison of two subcutaneous interferon beta 1a dosages for multiple sclerosis

Oxidative stress and inflammation biomarkers in the blood of patients with Huntington's disease

NGF and nitrosative stress in patients with Huntington's disease

Multiple sclerosis in Latin America: A different disease course severity? A collaborative study from the MSBase Registry

Suchergebnisse filtern